Levophed and Midazolam drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Levophed (norepinephrine bitartrate) and Midazolam (midazolam). Common drug interactions include aspartate aminotransferase increased among females and septic shock among males.
The phase IV clinical study analyzes what interactions people have when they take Levophed and Midazolam. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.
What is Levophed?
Levophed has active ingredients of norepinephrine bitartrate. eHealthMe is studying from 2,047 Levophed users. Check the latest studies of Levophed.
What is Midazolam?
Midazolam has active ingredients of midazolam. eHealthMe is studying from 11,246 Midazolam users. Check the latest studies of Midazolam.
42 people who take Levophed and Midazolam together, and have interactions are studied.

What are the common drug interactions of Levophed and Midazolam, by gender? *:
female:
- Aspartate aminotransferase increased
- Alanine aminotransferase increased
- Cardiac arrest
- Disease complication
- Hepatic steatosis (fatty liver disease)
- Ischaemic hepatitis (decreased blood supply to the liver resulting in injury to liver cells)
- Lymphadenopathy (disease or enlargement of lymph nodes)
- Platelet count decreased
male:
- Septic shock (shock due to blood infection)
- Alanine aminotransferase increased
- Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
- Urinary tract infection
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Acute respiratory distress syndrome
- Blood alkaline phosphatase increased
- Blood creatinine increased
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Acute hepatic failure
What are the common drug interactions of Levophed and Midazolam, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Aspartate aminotransferase increased
- Blood calcium decreased
- Blood creatinine increased
- Blood urea increased
- Cardiogenic shock (inadequate circulation of blood)
- Haematocrit decreased
- Septic shock (shock due to blood infection)
- White blood cell count increased
- Activated partial thromboplastin time prolonged
- Alanine aminotransferase increased
30-39:
- Alanine aminotransferase increased
- Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
40-49:
- Alanine aminotransferase increased
- Abdominal sepsis (abdominal infection)
- Blood alkaline phosphatase increased
- Gastric ulcer perforation (stomach hole due to ulcer)
- Hepatitis (inflammation of the liver)
- Myocarditis (inflammation of heart muscle myocardium)
50-59:
- Septic shock (shock due to blood infection)
- Duodenal ulcer haemorrhage (bleeding duodenal ulcer)
- Malignant neoplasm of renal pelvis (cancer tumour of ureter)
- Melaena (the passage of black, tarry stools)
- Oesophageal varices haemorrhage (bleeding from extremely dilated sub-mucosal veins in the lower third of the oesophagus)
- Pneumonia
- Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
- Urinary tract infection
- Hypokalaemia (low potassium)
- Acute hepatic failure
60+:
- Haemorrhage (bleeding)
- Alanine aminotransferase increased
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Blood alkaline phosphatase increased
- Blood bilirubin increased
- Blood fibrinogen decreased
- Bradycardia (abnormally slow heart action)
- Death
- Hepatic failure (liver failure)
- Hypotension (abnormally low blood pressure)
What are the existing conditions these people have? *
- Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 10 people, 23.81%
- Sedation: 6 people, 14.29%
- Pneumonia: 6 people, 14.29%
- Hypotension (abnormally low blood pressure): 6 people, 14.29%
- Fever: 6 people, 14.29%
- Pain: 4 people, 9.52%
- Type 2 Diabetes: 3 people, 7.14%
- Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 3 people, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Levophed and Midazolam?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Levophed and Midazolam:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Levophed:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Midazolam:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Levophed and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Midazolam and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on norepinephrine bitartrate and midazolam (the active ingredients of Levophed and Midazolam, respectively), and Levophed and Midazolam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Bystolic cause Acute Upper Airway Obstruction? - 3 seconds ago
- Drug interactions of Isradipine and Clonazepam - 3 seconds ago
- Sleep Disorder and Escherichia Urinary Tract Infection - 8 seconds ago
- Drug interactions of Amlodipine and Aminophylline - 25 seconds ago
- Botox vs. Paxil, side effect and effectiveness comparison - 25 seconds ago
- Could Intal cause Vomiting Aggravated? - 36 seconds ago
- Could Omeprazole cause White Blood Cells Urine Positive? - 37 seconds ago
- Could Erelzi cause Movement Disorder? - 39 seconds ago
- Could Luvox cause Haemorrhage? - 39 seconds ago
- Could Actos cause Oral Candidiasis? - 41 seconds ago